Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jan 8, 2020

Dr. Asher Nathan, CEO of NeoTX talks about the company's work developing immunotherapies for a wide range of solid tumors using their proprietary Selective T Cell Redirection (STR) platform.  This technology enables therapies that bind a genetically engineered super antigen to the tumor surface which trigger a native, controlled immune response that can kill the cancer with potentially fewer side effects than currently available therapies.  Asher discusses the company's lead STR molecule, NAP, which is being developed to treat advanced cancers.  NAP, which has potential as both a monotherapy and in combination with checkpoint inhibitors, is currently in a Phase 1B clinical trial in collaboration with AstraZeneca.

#immunotherapy  #immunotherapies  #AntiCancer  #SolidTumors  #Tcell  #Antigen  #Cancer  #Monotherapy  #Checkpointinhibitors  #Immunomodulators

 NeoTX.com

Listen to the podcast here

NeoTX